We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.94B
AUM Growth
+$2.67B
Cap. Flow
+$2.4B
Cap. Flow %
40.37%
Top 10 Hldgs %
19.09%
Holding
6,103
New
843
Increased
2,477
Reduced
2,101
Closed
546

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$206M
2
MSFT icon
Microsoft
MSFT
+$179M
3
AMZN icon
Amazon
AMZN
+$114M
4
TSLA icon
Tesla
TSLA
+$84M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$59.8M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$685M
2
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$54.5M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$42.1M
4
VOO icon
Vanguard S&P 500 ETF
VOO
+$27.7M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 20.76%
2 Financials 11.47%
3 Healthcare 11.18%
4 Consumer Discretionary 10.98%
5 Communication Services 8.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPRB
4326
Spruce Biosciences
SPRB
$142M
$11K ﹤0.01%
9
+3
+50% +$4.61K
SNAX
4327
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
$11K ﹤0.01%
+69
New +$11.4K
HMNF
4328
DELISTED
HMN Financial Inc
HMNF
$11K ﹤0.01%
528
-193
-27% -$3.73K
CNTG
4329
DELISTED
Centogene N.V. Common Shares
CNTG
$11K ﹤0.01%
889
-712
-44% -$8.5K
FNCB
4330
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
$11K ﹤0.01%
1,478
-6,428
-81% -$46.2K
VIA
4331
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$11K ﹤0.01%
208
-24
-10% -$1.29K
JOAN
4332
DELISTED
JOANN, Inc. Common Stock
JOAN
$11K ﹤0.01%
+1,100
New +$12.2K
NETI
4333
DELISTED
Eneti Inc.
NETI
$11K ﹤0.01%
502
-3,084
-86% -$62K
ACGN
4334
DELISTED
Aceragen Inc
ACGN
$11K ﹤0.01%
475
+84
+21% +$6.29K
BWAC
4335
DELISTED
BETTER WORLD ACQUISITION CORP. Common Stock
BWAC
$11K ﹤0.01%
+1,077
New +$11.1K
NYMX
4336
DELISTED
Nymox Pharmaceutical Corp
NYMX
$11K ﹤0.01%
5,010
-20,603
-80% -$54.3K
SIOX
4337
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$11K ﹤0.01%
4,079
-14,227
-78% -$40.2K
OIIM
4338
DELISTED
02Micro International
OIIM
$11K ﹤0.01%
+1,294
New +$11.1K
HYRE
4339
DELISTED
HyreCar Inc. Common Stock
HYRE
$11K ﹤0.01%
1,100
-6,378
-85% -$62.8K
ELOX
4340
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$11K ﹤0.01%
82
-98
-54% -$15K
ZVO
4341
DELISTED
Zovio Inc. Common Stock
ZVO
$11K ﹤0.01%
+2,710
New +$14.4K
CYBE
4342
DELISTED
Cyberoptics Corp
CYBE
$11K ﹤0.01%
406
-2,513
-86% -$65.3K
LFTR
4343
DELISTED
Lefteris Acquisition Corp. Class A Common Stock
LFTR
$11K ﹤0.01%
1,114
-186
-14% -$1.96K
PMVC
4344
DELISTED
PMV Consumer Acquisition Corp.
PMVC
$11K ﹤0.01%
+1,176
New +$12K
BBQ
4345
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$11K ﹤0.01%
1,556
-305
-16% -$1.88K
PRPB.U
4346
DELISTED
CC Neuberger Principal Holdings II
PRPB.U
$11K ﹤0.01%
1,067
-1,123
-51% -$12.3K
NSEC
4347
DELISTED
National Security Group Inc
NSEC
$11K ﹤0.01%
1,171
+256
+28% +$2.9K
OCA
4348
DELISTED
Omnichannel Acquisition Corp.
OCA
$11K ﹤0.01%
+1,100
New +$11.1K
EVFM
4349
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$11K ﹤0.01%
413
+70
+20% +$3.18K
ROCRU
4350
DELISTED
Roth CH Acquisition III Co. Unit
ROCRU
$11K ﹤0.01%
+1,060
New +$10.6K
172 173
174
175 176

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2021 Portfolio in Review

As of Q1 2021, Tower Research Capital (TRC) held 6,103 positions worth $5.94B, up 82% from $3.27B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) deployed $2.4B of net new capital in Q1 2021, opening 843 new positions and adding to 2,477 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 9.7% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $685M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2021 buy was iShares Russell 1000 Growth ETF: 262,344 shares worth $15.9M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2021, an estimated $206M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $685M.
  • Tower Research Capital (TRC) fully exited ARK Genomic Revolution ETF in Q1 2021, selling an estimated $7.27M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $5.94B portfolio in Q1 2021.
  • Tower Research Capital (TRC) opened 843 new positions and closed 546 in Q1 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 82% quarter-over-quarter to $5.94B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.